Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Alvogen
Pharma
Bausch notches win in Xifaxan case against Alvogen
The D.C. federal court denied Alvogen's bid to force the FDA to grant full approval to its proposed Xifaxan generic.
Zoey Becker
Nov 3, 2023 11:17am
BMS, generics companies face new suit over Revlimid 'monopoly'
Nov 22, 2022 11:38am
J&J-Legend, Sanofi, LG Chem-Aveo—Fierce Pharma Asia
Oct 21, 2022 10:15am
AstraZeneca and Alvogen receive wrist slap from Korea's FTC
Oct 13, 2022 1:40pm
AbbVie's court win extends the life of blockbuster Imbruvica
Aug 31, 2021 11:03am
Advent's Zentiva grabs Romanian drugmaker Labormed from Alvogen
Oct 28, 2019 10:38am
